Biology of Blood and Marrow Transplantation
Volume 17, Issue 5 , Pages 632-639 , May 2011

Humoral and Cellular Immunity to Primary H1N1 Infection in Patients with Hematologic Malignancies following Stem Cell Transplantation

  • Paula Garland

      Affiliations

    • Department of Hematology, Imperial College London, London, UK
    • The first two authors contributed equally to the manuscript.
    • ,
  • Hugues de Lavallade

      Affiliations

    • Department of Hematology, Imperial College London, London, UK
    • The first two authors contributed equally to the manuscript.
    • ,
  • Takuya Sekine

      Affiliations

    • Department of Hematology, Imperial College London, London, UK
    • ,
  • Katja Hoschler

      Affiliations

    • Respiratory Virus Unit, Health Protection Agency, London, UK
    • ,
  • Shiranee Sriskandan

      Affiliations

    • Department of Virology, Imperial College Healthcare NHS Trust, London, UK
    • ,
  • Parind Patel

      Affiliations

    • Department of Intensive Care Medicine, Imperial College Healthcare NHS Trust, London, UK
    • ,
  • Stephen Brett

      Affiliations

    • Department of Intensive Care Medicine, Imperial College Healthcare NHS Trust, London, UK
    • ,
  • Kate Stringaris

      Affiliations

    • Department of Hematology, Imperial College London, London, UK
    • ,
  • Eva Loucaides

      Affiliations

    • Department of Hematology, Imperial College London, London, UK
    • ,
  • Katherine Howe

      Affiliations

    • Department of Hematology, Imperial College London, London, UK
    • ,
  • David Marin

      Affiliations

    • Department of Hematology, Imperial College London, London, UK
    • ,
  • Ed Kanfer

      Affiliations

    • Department of Hematology, Imperial College London, London, UK
    • ,
  • Nichola Cooper

      Affiliations

    • Department of Hematology, Imperial College London, London, UK
    • ,
  • Donald Macdonald

      Affiliations

    • Department of Hematology, Imperial College London, London, UK
    • ,
  • Amin Rahemtulla

      Affiliations

    • Department of Hematology, Imperial College London, London, UK
    • ,
  • Mark Atkins

      Affiliations

    • Department of Virology, Imperial College Healthcare NHS Trust, London, UK
    • ,
  • Akila Danga

      Affiliations

    • Department of Intensive Care Medicine, Imperial College Healthcare NHS Trust, London, UK
    • ,
  • Dragana Milojkovic

      Affiliations

    • Department of Hematology, Imperial College London, London, UK
    • ,
  • Ian Gabriel

      Affiliations

    • Department of Hematology, Imperial College London, London, UK
    • ,
  • Ahmad Khoder

      Affiliations

    • Department of Hematology, Imperial College London, London, UK
    • ,
  • Abdullah Alsuliman

      Affiliations

    • Department of Hematology, Imperial College London, London, UK
    • ,
  • Jane Apperley

      Affiliations

    • Department of Hematology, Imperial College London, London, UK
    • ,
  • Katayoun Rezvani

      Affiliations

    • Department of Hematology, Imperial College London, London, UK
    • Corresponding Author InformationCorrespondence and reprint requests: Dr Katayoun Rezvani, Academic Department of Hematology, 4th Floor Commonwealth Building, Hammersmith Hospital, Du Cane Road, London W12, UK.

Received 22 June 2010 ,Accepted 3 August 2010.

References 

  1. Nichols WG, Corey L, Gooley T, et al. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood. 2001;98:573–578
  2. Garcia-Suarez J, Martin Y, Callejas M, et al. Favourable outcome of pneumonia due to novel influenza A/H1N1 2009 virus in a splenectomised adult patient undergoing therapy for non-Hodgkin lymphoma. Br J Haematol. Epub 2009 Nov 16;148(5):808–810
  3. Redelman-Sidi G, Sepkowitz KA, Huang CK, et al. 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect. Epub 2010 Feb 4;60(4):257–263
  4. Rozovski U, Herishanu Y, Gipstein L, et al. Fatal H1N1 influenza infection in an allo-SCT recipient. Bone Marrow Transplant. 2010;Letter, January 25
  5. Seiter K, Nadelman RB, Liu D, et al. Novel influenza A (H1N1) in patients with hematologic malignancies. J Clin Oncol. 2010;28:e27–e29
  6. World Health Organization–CDC protocol of real time RTPCR for influenza A (H1N1). 2009, April 28; available online at:http://www.who.int/csr/resources/publications/swineflu/CDCRealtimeRTPCR_SwineH1Assay-2009_20090430.pdf.
  7. Ellis JS, Zambon MC. Molecular analysis of an outbreak of influenza in the United Kingdom. Eur J Epidemiol. 1997;13:369–372
  8. Nicholson KG, Colegate AE, Podda A, et al. Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. Lancet. 2001;357:1937–1943
  9. Clark TW, Pareek M, Hoschler K, et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med. 2009;361:2424–2435
  10. Miller E, Hoschler K, Hardelid P, et al. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet. 2010, Mar 27;375(9720):1100–1108
  11. Chattopadhyay PK, Yu J, Roederer M. A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles. Nat Med. 2005;11:1113–1117
  12. Rezvani K, Yong AS, Tawab A, et al. Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia. Blood. 2009;113:2245–2255
  13. Hui DS, Lee N, Chan PK. Clinical management of pandemic (H1N1) infection. Chest. 2009, Apr;137(4):916–925
  14. Gaur AH, Bagga B, Barman S, et al. Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. N Engl J Med. 2010;362:88–89
  15. Kidd IM, Down J, Nastouli E, et al. H1N1 pneumonitis treated with intravenous zanamivir. (Case Report) Lancet. 2009;374:1036
  16. Chowell G, Bertozzi SM, Colchero MA, et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med. 2009;361:674–679
  17. Donaldson LJ, Rutter PD, Ellis BM, et al. Comparisons with recent flu mortality. (Letter) BMJ. 2010;340:c612
  18. Perez-Padilla R, Rosa-Zamboni D, Ponce de LS, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009;361:680–689
  19. Cao B, Li XW, Mao Y, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med. 2009;361:2507–2517
  20. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. N Engl J Med. 2009;361:1935–1944
  21. Plennevaux E, Sheldon E, Blatter M, et al. Immune response after a single vaccination against 2009 influenza A H1N1 in the USA: a preliminary report of two randomised controlled phase 2 trials. Lancet. 2010;375:41–48
  22. Greenberg ME, Lai MH, Hartel GF, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med. 2009;361:2405–2413
  23. Ljungman P, Nahi H, Linde A. Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study. Br J Haematol. 2005;130:96–98
  24. Takata T, Suzumiya J, Ishikawa T, et al. Attenuated antibody reaction for the primary antigen but not for the recall antigen of influenza vaccination in patients with non-Hodgkin B-cell lymphoma after the administration of rituximab-CHOP. J Clin Exp Hematol. 2009;49:9–13
  25. Ge X, Tan V, Bollyky PL, et al. Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus. J Virol. 2010;84:3312–3319
  26. Greenbaum JA, Kotturi MF, Kim Y, et al. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci USA. 2009;106:20365–20370
  27. Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009;361:1945–1952
  28. Pascua PN, Song MS, Lee JH, et al. Evaluation of the efficacy and cross-protectivity of recent human and swine vaccines against the pandemic (H1N1) 2009 virus infection. PLoS One. 2009;4:e8431
  29. Louie JK, Acosta M, Winter K, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 2009;302:1896–1902

 Financial disclosure: See Acknowledgments on page 638.

PII: S1083-8791(10)00340-X

doi: 10.1016/j.bbmt.2010.08.002

Biology of Blood and Marrow Transplantation
Volume 17, Issue 5 , Pages 632-639 , May 2011

Article Tools

* Image Usage & Resolution